Stephen Feng

Stephen Feng is a seasoned professional with extensive experience in healthcare strategy and business development. They currently serve as the Senior Director of HCO Strategy for CardioMetabolic Health at Eli Lilly and Company, where they lead initiatives related to Mounjaro and collaborate with various teams to develop marketing plans and oversee product launches. Previously, they held multiple roles at Eli Lilly, including an advisory position focused on international business units and a leadership role in US HCO strategy. Stephen also has experience in business development with DHL Supply Chain and TNT, fostering growth in their respective markets. They hold a Master's degree from the University of Southern California and completed an Executive Education program at Harvard Medical School.